VIGL Volume dana dhuwit perusahaan Vigil Neuro

Logo grafis vigilneuro.com (VIGL)

Vigil Neuroscience attracts leading neuroimmunologists with its cutting-edge research on brain microglia. The company's financial viability is based on the success of clinical programs for treating rare pathologies. The business relies on unique developments, making it a defensive asset independent of macroeconomic factors. The company's cash balance demonstrates liquidity, where the value of 0.07 characterizes this level.

VIGL - Aset likuid perusahaan Vigil Neuroscience ing rentang 04.07.2022 - 16.08.2025

Vigil Neuroscience (VIGL) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:
Analisis fundamental perusahaan:Vigil Neuroscience, Inc.
Produk mawa merek Vigil Neuro

Capital volume distinguishes stable enterprises from speculative assets. The stability of Vigil Neuroscience (VIGL) is confirmed by the exclusivity of its molecules and FDA support, which prevents patient attrition. This cash balance chart illustrates the liquid reserves necessary to cover operating expenses during revenue declines. This price action reflects the burn rate of the cash cushion during periods of market volatility. A high cash balance guarantees the financial viability of Vigil Neuroscience (VIGL).

Pesaing Vigil Neuroscience (VIGL)

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AMLX (amylyx.com)|Aset likuid perusahaan Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anavex|CBLL (CeriBell Inc) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PRTA|Dana dhuwit perusahaan Alector Inc.|Cadangan dhuwit perusahaan Annexon, Inc. ANNX|Dana dhuwit perusahaan Omeros Corp (OMER)|NGNE (Neurogene Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan AC Immune Inc ACIU|Posisi dhuwit perusahaan Voyager Corp|Neumora Corp - Volume dana dhuwit perusahaan|scilexholding.com (SCLX) - Dhuwit awis perusahaan|Tevogen Bio Holdings, Inc. (TVGN) - Dana dhuwit perusahaan|Alpha Cognition Corp (ACOG) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan CGTX|Dhuwit awis lan setara dhuwit awis perusahaan IKT (Inhibikase)|Volume dana dhuwit perusahaan SAVA|Assertio - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan COYA (Coya Therapeutics)|Volume dana dhuwit perusahaan Vistagen Therapeutics VTGN|OVID: Dhuwit awis perusahaan|ABOS - Volume dana dhuwit perusahaan|CRVO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alterity Therapeutics Ltd. (ATHE)|Dana dhuwit perusahaan Clene Inc.|pepgen.com (PEPG) - Aset likuid perusahaan|Dhuwit awis perusahaan JUNS (jupiterneurosciences.com)|Dana dhuwit perusahaan RLMD (Relmada Corp)|Annovis Bio, Inc. - Dhuwit awis perusahaan|Posisi dhuwit perusahaan Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Volume dana dhuwit perusahaan|KLTO - Volume dana dhuwit perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Dhuwit awis perusahaan|RVPH - Aset likuid perusahaan|Dana dhuwit perusahaan MetaVia|Dhuwit awis lan setara dhuwit awis perusahaan NRXS (neuraxis.com)|Dana dhuwit perusahaan Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan NEUP (Neuphoria Therapeutics)|Sisa dhuwit perusahaan NERV|ATHA - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan ADXN|ALZN (Alzamend Neuro) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan CYCN|PTIX (Protagenic Therapeutics, Inc.) - Volume dana dhuwit perusahaan|KTTA: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Cortigent Medical (CRGT)|ATXI - Cadangan dhuwit perusahaan|Volume dana dhuwit perusahaan BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Cadangan dhuwit perusahaan|CHRO: Dhuwit awis perusahaan|Eliem Therapeutics Inc. (ELYM) - Dhuwit awis perusahaan|Intra-Cellular Therapies Inc. (ITCI) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan LBPH (Longboard Pharmaceuticals)|MRNS (marinuspharma.com) - Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan NKGN (NKGen Biotech Inc)|Volume dana dhuwit perusahaan NRBO|Dhuwit awis perusahaan Sage Therapeutics Inc SAGE|Dana dhuwit perusahaan Synaptogenix SNPX|TRVN: Dhuwit awis lan setara dhuwit awis perusahaan|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE